0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-06-01 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 12614503 2024-06-01 2025-05-31 12614503 2025-05-31 12614503 2024-05-31 12614503 2023-06-01 2024-05-31 12614503 2024-05-31 12614503 2023-05-31 12614503 bus:Director1 2024-06-01 2025-05-31 12614503 core:WithinOneYear 2025-05-31 12614503 core:WithinOneYear 2024-05-31 12614503 core:ShareCapital 2025-05-31 12614503 core:ShareCapital 2024-05-31 12614503 core:RetainedEarningsAccumulatedLosses 2025-05-31 12614503 core:RetainedEarningsAccumulatedLosses 2024-05-31 12614503 bus:Director1 2024-05-31 12614503 bus:Director1 2025-05-31 12614503 bus:Director1 2023-05-31 12614503 bus:Director1 2024-05-31 12614503 bus:Director1 2023-06-01 2024-05-31 12614503 bus:SmallEntities 2024-06-01 2025-05-31 12614503 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 12614503 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 12614503 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 12614503 bus:FullAccounts 2024-06-01 2025-05-31
COMPANY REGISTRATION NUMBER: 12614503

ARTIS SKIN CARE LTD

FILLETED UNAUDITED FINANCIAL STATEMENTS

31 May 2025

ARTIS SKIN CARE LTD

STATEMENT OF FINANCIAL POSITION

31 May 2025

| 2025 | 2024
Note | £ | £ | £

Current assets

Stocks | 12,908 |  | 14,149
Debtors | 4 | 164 |  | –
Cash at bank and in hand | 7,577 |  | 4,531
| --------- |  | ---------
| 20,649 |  | 18,680

Creditors: amounts falling due within one year | 5 | 26,738 |  | 22,916
| --------- |  | ---------
Net current liabilities |  | 6,089 | 4,236
|  | ------- | -------
Total assets less current liabilities |  | ( 6,089) | ( 4,236)
|  | ------- | -------
Net liabilities |  | ( 6,089) | ( 4,236)
|  | ------- | -------

Capital and reserves

Called up share capital |  | 1 | 1
Profit and loss account |  | ( 6,090) | ( 4,237)
|  | ------- | -------
Shareholders deficit |  | ( 6,089) | ( 4,236)
|  | ------- | -------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

ARTIS SKIN CARE LTD

STATEMENT OF FINANCIAL POSITION (continued)

31 May 2025
These financial statements were approved by the board of directors and authorised for issue on 20 October 2025 , and are signed on behalf of the board by:

Mr P Banwell |
Director |

Company registration number: 12614503

ARTIS SKIN CARE LTD

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 MAY 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 168 Church Road, Hove, East Sussex, BN3 2DL.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
No material uncertainties, that may cast significant doubt about the ability of the company to continue as a going concern, have been identified by the director. The director considers that the uncertainty caused in the company's industry as a result of Coronavirus and the recovery from the restrictions put in place by the government should not materially affect the company's ability to continue as a going concern.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied, stated net of discounts. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually on despatch of the goods, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Debtors

| 2025 | 2024
| £ | £
Trade debtors | 164 | –
| ---- | ----

5. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Bank loans and overdrafts | 228 | –
Trade creditors | 6,396 | 4,851
Other creditors | 20,114 | 18,065
| --------- | ---------
| 26,738 | 22,916
| --------- | ---------

6. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:

| 2025
|  | Balance brought forward | Advances/ (credits) to the director | Balance outstanding
|  | £ | £ | £
| Mr P Banwell | ( 4,703) | 772 | ( 3,931)
|  | ------- | ---- | -------

| 2024
|  | Balance brought forward | Advances/ (credits) to the director | Balance outstanding
|  | £ | £ | £
| Mr P Banwell | ( 3,980) | ( 723) | ( 4,703)
|  | ------- | ---- | -------